Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
884.9 USD | -0.65% | -1.28% | +0.81% |
06:25pm | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
02:45pm | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.81% | 95.71B | |
-1.99% | 103B | |
+1.69% | 22.02B | |
-16.98% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.05% | 15.52B | |
+3.22% | 13.86B | |
+35.02% | 12.04B | |
-25.38% | 8.08B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. - Special Call